During this time, people may notice more fat accumulating around their belly
Antioxidant and cellular protection support*
This association held across different ages, sexes, and ethnicities, and remained consistent in follow-ups of up to three years
7 Clinical Trials Testing GLP-1 Receptor Agonists in Patients with AD or PD (Table 1) 7.1 A Pilot Study Testing Exendin-4 (Byetta , Bydureon , Exenatide) in PD A pilot study of the potential neuroprotective effects of GLP-1 receptor agonist exendin-4 was conducted as an open-label trial in participants with PD (NCT01174810)
When symptoms do occur, they typically fall into two categories: local injection site reactions and systemic manifestations that may suggest reduced medication efficacy
Trademark Disclaimer: All trademarks, brand names, and laboratory names referenced on this page are the property of their respective owners